Mohammad B Haskali

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 8

Top Venues

Journal of medicinal chemistry

Angewandte Chemie (International ed. in English)

Chemistry (Weinheim an der Bergstrasse, Germany)

RSC medicinal chemistry

Peter MacCallum Cancer Centre

University of Melbourne (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Peter MacCallum Cancer Centre Oct 3o 2016

Australia

Radiopharmaceutical Scientist :: Cancer Imaging

Education History

University of Melbourne Mar 1o 2009 - Aug 31o 2015

Australia

PHD :: School Of Chemistry

Publications

Sanjay Telu, Susovan Jana, Mohammad B Haskali, Bo Yeun Yang, Jimmy Erik Jakobsson, Qunchao Zhao, Karla M Ramos-Torres, Pedro Brugarolas, Victor W Pike
Broad-scope Syntheses of [ 11 C/ 18 F]Trifluoromethylarenes from Aryl(mesityl)iodonium Salts. Chemistry (Weinheim an der Bergstrasse, Germany) (2023)
Alicia Corlett, Jo-Anne Pinson, Marwa N Rahimi, Jessica Van Zuylekom, Carleen Cullinane, Benjamin Blyth, Philip E Thompson, Craig A Hutton, Peter D Roselt, Mohammad B Haskali
Development of Highly Potent Clinical Candidates for Theranostic Applications against Cholecystokinin-2 Receptor Positive Cancers. Journal of medicinal chemistry (2023)
Mohammad B Haskali, Peter D Roselt, Terence J O'Brien, Craig A Hutton, Idrish Ali, Lucy Vivash, Bianca Jupp
Effective Preparation of [ 18 F]Flumazenil Using Copper-Mediated Late-Stage Radiofluorination of a Stannyl Precursor. Molecules (Basel, Switzerland) 27 (18) (2022)
Asif Noor, Jessica K Van Zuylekom, Stacey E Rudd, Peter D Roselt, Mohammad B Haskali, Eddie Yan, Michael Wheatcroft, Rodney J Hicks, Carleen Cullinane, Paul S Donnelly
Imaging Somatostatin Positive Tumors with Tyr3-Octreotate/Octreotide Conjugated to Desferrioxamine B Squaramide Radiolabeled with either Zirconium-89 or Gallium-68. Bioconjugate chemistry 32 (7) (2021)
Shuiyu Lu, Mohammad B Haskali, Kevin M Ruley, Nicolas J-F Dreyfus, Susan L DuBois, Soumen Paul, Jeih-San Liow, Cheryl L Morse, Aneta Kowalski, Robert L Gladding, Jeremy Gilmore, Adrian J Mogg, S Michelle Morin, Peter J Lindsay-Scott, J Craig Ruble, Nancy A Kant, Sergey Shcherbinin, Vanessa N Barth, Michael P Johnson, Maria Cuadrado, Enrique Jambrina, Andrew J Mannes, Hugh N Nuthall, Sami S Zoghbi, Cynthia D Jesudason, Robert B Innis, Victor W Pike
PET ligands [18F]LSN3316612 and [11C]LSN3316612 quantify O-linked-β-N-acetyl-glucosamine hydrolase in the brain. Science translational medicine 12 (543) (2021)
Alicia Corlett, Marc-Antoine Sani, Jessica Van Zuylekom, Ching-Seng Ang, Elisabeth von Guggenberg, Carleen Cullinane, Benjamin Blyth, Rodney J Hicks, Peter D Roselt, Philip E Thompson, Craig A Hutton, Mohammad B Haskali
A New Turn in Peptide-Based Imaging Agents: Foldamers Afford Improved Theranostics Targeting Cholecystokinin-2 Receptor-Positive Cancer. Journal of medicinal chemistry 64 (8) (2021)
Mohammad B Haskali, Ashleigh L Farnsworth, Peter D Roselt, Craig A Hutton
4-Nitrophenyl activated esters are superior synthons for indirect radiofluorination of biomolecules. RSC medicinal chemistry 11 (8) (2020)
Nicholas A Zia, Carleen Cullinane, Jessica K Van Zuylekom, Kelly Waldeck, Lachlan E McInnes, Gojko Buncic, Mohammad B Haskali, Peter D Roselt, Rod John Hicks, Paul S Donnelly
A Bivalent Inhibitor of Prostate Specific Membrane Antigen Radiolabeled with Copper-64 with High Tumor Uptake and Retention. Angewandte Chemie (International ed. in English) 58 (42) (2019)

Mohammad B Haskali.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mohammad B Haskali